You are here: Industry Insights > Astepro

News List

FDA Approves Over-the-Counter Nasal Antihistamine americanpharmaceuticalreview
June 23, 2021
The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
US approval for OTC use of Bayer’s Astepro pharmatimes
June 22, 2021
The US Food and Drug Administration (FDA) has approved Bayer’s steroid-free antihistamine nasal spray Astepro for over-the-counter use.
FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use drugs
June 18, 2021
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC) product for the temporary relief of nasal congestion, runny nose, sneezing and itchy nose due.
FDA Approves a Nasal Antihistamine for Nonprescription Use fda.gov
June 18, 2021
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.